ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,893.60
      0.00%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.26
      -0.18%
      Bitcoin
      57,284.88
      1.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX
      6. Dye and Durham Limited (DND)

      7. Dye and Durham Limited (DND) News

      DND

      Dye and Durham (DND)

      Dye and Durham Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:TSX:DND
      DateTimeSourceHeadlineSymbolCompany
      10/01/20148:30AMPR Newswire (US)Ranbaxy Launches ABSORICA® (isotretinoin) 25 mg and 35 mg Capsules in the U.S. MarketTSX:DNDDye and Durham Limited
      09/03/20147:00AMPR Newswire (Canada)Cipher Pharmaceuticals Inc. to present at Rodman & Renshaw 16th Annual Global Investment ConferenceTSX:DNDDye and Durham Limited
      07/30/20147:00AMPR Newswire (Canada)Cipher reports financial results for Q2 2014TSX:DNDDye and Durham Limited
      07/24/20148:00AMPR Newswire (Canada)Cipher Pharmaceuticals and Ranbaxy Announce Distribution Agreement for Isotretinoin Product in BrazilTSX:DNDDye and Durham Limited
      07/16/201410:33AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q2 2014 Conference CallTSX:DNDDye and Durham Limited
      06/26/20147:00AMPR Newswire (Canada)Cipher Pharmaceuticals appoints Shawn Patrick O'Brien as CEOTSX:DNDDye and Durham Limited
      06/18/20147:00AMPR Newswire (Canada)Cipher Pharmaceuticals completes distribution and supply agreement for isotretinoin product in ChileTSX:DNDDye and Durham Limited
      06/05/20147:00AMPR Newswire (Canada)Cipher Pharmaceuticals Inc. to present at the 2014 Bloom Burton & Co. Healthcare Investor ConferenceTSX:DNDDye and Durham Limited
      05/05/20141:54PMPR Newswire (Canada)Cipher Pharmaceuticals Inc. Reports Voting Results from Annual General Meeting of ShareholdersTSX:DNDDye and Durham Limited
      05/02/20147:00AMPR Newswire (Canada)Cipher reports financial results for Q1 2014TSX:DNDDye and Durham Limited
      04/21/20148:00AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q1 2014 conference call and 2013 Annual General Meeting of ShareholdersTSX:DNDDye and Durham Limited
      03/25/20149:16AMPR Newswire (Canada)Cipher appoints Thomas Wellner to BoardTSX:DNDDye and Durham Limited
      03/14/20147:00AMPR Newswire (Canada)Cipher announces management changeTSX:DNDDye and Durham Limited
      02/26/20147:00AMPR Newswire (Canada)Cipher reports record financial results for 2013TSX:DNDDye and Durham Limited
      02/12/20148:00AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2013 conference callTSX:DNDDye and Durham Limited
      02/05/20147:30AMPR Newswire (Canada)Cipher Appoints Gerald McDole as Chair of the BoardTSX:DNDDye and Durham Limited
      01/21/20147:00AMPR Newswire (Canada)Cipher achieves sales milestone for AbsoricaTSX:DNDDye and Durham Limited
      12/30/20138:00AMPR Newswire (Canada)Cipher Announces Change to Board of DirectorsTSX:DNDDye and Durham Limited
      10/30/201311:30AMPR Newswire (Canada)Cipher reports record financial results for Q3 2013TSX:DNDDye and Durham Limited
      10/30/20137:00AMPR Newswire (Canada)Cipher reports record financial results for Q3 2013TSX:DNDDye and Durham Limited
      10/22/201311:01AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q3 2013 Conference CallTSX:DNDDye and Durham Limited
      09/25/20138:30AMMarketwired CanadaAtlantis Systems Corp. Awarded Contract for De-Icing Operator Phase Two Training Program by Department of National DefenceTSX:DNDDye and Durham Limited
      09/19/201310:59AMPR Newswire (Canada)IIROC Trade Resumption - DNDTSX:DNDDye and Durham Limited
      09/19/201310:59AMPR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - DNDTSX:DNDDye and Durham Limited
      09/19/201310:45AMPR Newswire (Canada)Cipher's Partner Ranbaxy receives Paragraph IV CertificationTSX:DNDDye and Durham Limited
      09/19/20139:38AMPR Newswire (Canada)IIROC Trading Halt - DND (all issues)TSX:DNDDye and Durham Limited
      09/19/20139:38AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - DND (toutes les émissions)TSX:DNDDye and Durham Limited
      09/13/20136:30PMPR Newswire (Canada)Indices S&P Dow Jones annonce des modifications aux indices canadiens S&P/TSXTSX:DNDDye and Durham Limited
      09/13/20135:15PMPR Newswire (Canada)S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian IndicesTSX:DNDDye and Durham Limited
      07/17/20139:00AMPR Newswire (Canada)Notice of Cipher Pharmaceuticals Inc. Q2 2013 Conference CallTSX:DNDDye and Durham Limited
       Showing the most relevant articles for your search:TSX:DND

      Your Recent History

      BIT
      NSCIT5399588
      Cassa Depositi e Prestit...
      Delayed Upgrade Clock